Mesenchymal stem cells and neurodegenerative disease

A L Whone, N J Scolding

Research output: Contribution to journalArticle (Academic Journal)peer-review

10 Citations (Scopus)


The prospect of cell therapy for incurable neurodegenerative disease excites scientists, the public, and patients alike. Clinical and scientific enthusiasm must, however, always be tempered by methodological rigor and by the overwhelming imperative of protecting vulnerable sufferers. We tentatively suggest that, in the case of autologous mesenchymal stem cells (MSCs), the balance between our current understanding of their biology and an informed assessment of their probable safety allows a case to be made for cautious pilot clinical studies.
Original languageEnglish
Pages (from-to)19-20
Number of pages2
JournalClinical Pharmacology and Therapeutics
Issue number1
Publication statusPublished - 2009


Dive into the research topics of 'Mesenchymal stem cells and neurodegenerative disease'. Together they form a unique fingerprint.

Cite this